BioCentury
ARTICLE | Finance

3Q Stock Wrap-Up: Make it a double

All biotech tiers up in 3Q13; large caps up 46% on the year

October 7, 2013 7:00 AM UTC

For the second time this year, all market cap segments closed the quarter in the black. Large caps valued at $5 billion and above gained ground for the fifth consecutive quarter. They added 12%, and are up 46% year to date.

Large caps were led by Pharmacyclics Inc., which gained 74% in 3Q13 to $138.26...